Ambry Genetics launches Fluidigm-based genomic research services
The BioMark HD System provides the sensitivity required to study gene expression profiles down to the single-cell level and high throughput SNP genotyping and digital PCR for copy
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.